Kugathasan et al; Coronary Artery Calcification and Mortality P atients with severe mental illness (SMI)-including schizophrenia, bipolar disorder, and their related spectrum disorders-have a shortened life expectancy of nearly 20 years, compared with the general population. 1 Suicide contributes to this reduced life expectancy, but the majority of deaths are related to physical conditions, which accounts for up to 80% of all deaths in patients with SMI. 2 Cardiovascular disease, including coronary artery disease, is considered to be the main contributor to the increased mortality rates and shortened life expectancy in patients with SMI. 2, 3 In the general population, there has been a decrease in cardiovascular mortality over the past decades, 4 primarily as a result of changes in lifestyle risk behaviors, secondary prophylactic treatment (eg, β-blockers, statins, and angiotensin-converting enzyme inhibitors), improvements within the diagnostic procedures (eg, coronary markers in myocardial infarction), as well as implementation of interventional cardiology (especially percutaneous coronary intervention). 5 Studies on mortality after cardiovascular disease have shown a lack of a similar improvement in outcomes in patients with SMI when compared with the general population. 6, 7 Although current literature on patients diagnosed with SMI have focused on outcomes related to hospitalized patients with acute cardiac events, 3 limited studies have reported early prediction and management of cardiovascular disease outcomes in patients with SMI. A majority of patients with SMI experience sudden cardiac death probably as a result of silent myocardial infarction, 8, 9 thus early prediction of mortality risk is fundamental for the preventive strategies in patients with SMI.
A more recent implemented tool within cardiology is the detection of coronary artery calcification (CAC), which is a well-described marker of coronary artery disease. 10 The CAC is measured by cardiac computed tomography (CCT), which is a noninvasive imaging technique using non-contrast-enhanced material, and the total amount of CAC is quantified by the Agatston score. 11 Presence, extent, and progression of CAC have shown to be associated with ischemic heart disease risk and risk of death. 12, 13 To date, no studies have used CAC to predict outcomes in patients with SMI. Thus, we aimed to investigate the severity of CAC and its effect on mortality rates in patients diagnosed with SMI using a large population-based Danish cohort.
METHODS
The authors declare that all supporting data are available within the article.
Data Source
We included all people registered in The Western Denmark Heart Registry (WDHR). The WDHR is a clinical database in Denmark, launched in 1999, and covering a catchment area of 3.3 million individuals (55% of the total Danish population); since 2008, it has also included procedures of CCT. 14 The WDHR was linked to the Danish National Patient Registry, which contains somatic as well as psychiatric in-and outpatient records since 1995 for the entire population of Denmark. We obtained information about the date of death from the Danish Cause of Death Register.
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Study Population
All patients who had undergone a CCT in the period from January 1, 2008 to December 31, 2016 were evaluated for inclusion in the present study. We only included patients with a recorded CAC score within the defined study period. Among eligible patients, we stratified patients into groups of SMI, as defined as a registered diagnosis of schizophrenia (International Classification of Diseases, Tenth Revision: F20) or bipolar disorder (International Classification of Diseases, Tenth Revision: F30+F31) from the Danish National Patient Registry. 16 The rest of the study population was considered as the comparison group from the general population. We excluded patients with no recorded CAC score, as well as patients below the age of 30 years at time of CCT. We chose this age cutoff to minimize the inclusion of patients with congenital heart disease.
CLINICAL PERSPECTIVE
Excess cardiovascular morbidity and mortality exist in patients with severe mental illness (SMI). A common challenge for clinicians is that patients with SMI lack in communicating and engage in health care plans as observed in the general population. Therefore, early prediction of cardiovascular disease and its effect on mortality is necessary to improve the prognosis of these patients. Coronary artery calcium is a quantitative marker of coronary heart disease, which can be used to predict mortality. We studied the association between calcium scoring and mortality in a cohort of people (48 747) who had undergone cardiac computed tomography in Denmark and divided the group into whether or not they had an SMI diagnosis. Our data showed that even in the group of low calcium score, we observed increased mortality in patients with SMI, as compared to the comparison group. Moreover, we also demonstrated that some of the excess mortality in the current study were related to noncardiovascular causes of death with a relatively few numbers of events. The current findings challenge the concept of using presence of coronary artery calcification and its association to mortality in patients with SMI, but more studies are needed to address the topic of early cardiovascular disease prediction in patients with SMI.
Outcome Measures
The primary outcome was the difference in CAC score between patients with SMI and the comparison group. The secondary outcome measure was all-cause mortality after CCT. All patients were followed from the time of CCT until the time of death or until December 31, 2016, whichever came first.
Cardiovascular Risk Factors
All cardiovascular risk factors were defined dichotomously, with smoking being defined as present if the patient reported being a smoker at the time of CCT. Diabetes mellitus was defined as being present if a medical history of diabetes mellitus or current use of any antidiabetics was reported in the WDHR. Hypertension was defined as being present if a blood pressure of ≥140/90 mm Hg or current treatment with any antihypertensive drugs was reported in the WDHR. Dyslipidemia was defined as being present if a medical record of elevated lipids or current use of statins was reported in the WDHR. Lastly, body mass index (BMI) was calculated as the patient's weight in kilograms divided by the square of height in meters, reported as a continuous variable.
Ethics
The data included clinical records from WDHR combined with Danish nationwide register data, which involved a large amount of personal data. Any processing of personal data was anonymized before analysis of data, and approval was received from the Danish Data Protection Agency (2008-58-0028) and the National Board of Health (FSEID-00002879). According to Danish Legislation, register-based research protocols do not require approval from the Ethics Committee.
Statistical Analyses
The distributions of baseline characteristics of each exposure group (SMI versus comparison group) were described by calculating mean and SD for continuous variables and frequencies, and percentages for categorical variables. In the baseline characteristics, we summarized demographics and illness history for both groups. We compared groups using independent sample t test for continuous variables and χ 2 tests for categorical variables. For both exposure groups, we presented a linear regression model to evaluate which variables were associated with CAC (used as a continuous variable). We performed a bootstrapping technique to estimate standard errors in the linear regression because CAC was not normally distributed.
To assess the difference in CAC severity between the patients with SMI and the comparison group, we categorized CAC into groups of low score (CAC ≤100) and high score (CAC >100) by age (≤60 versus >60) and compared frequencies by χ 2 test. We were not able to further divide the CAC score into smaller groups because of a limited number of SMI patients, as well as event rates.
The crude survival function of each of the exposure groups stratified by CAC score (≤100 versus >100) was estimated by the Kaplan-Meier estimator. Analyses of time to all-cause mortality were performed using crude and adjusted Cox proportional hazards regression to estimate hazard ratios (HR) of the effect of CAC score on the rate of death. We restricted the follow-up period to a maximum of 5 years after CCT. To investigate if the assumption of proportional hazards were met, we conducted Schoenfeld residuals, which showed proportional hazards for the results included in the current study. The effects of CAC score in the SMI and the comparison group was assessed by including the interaction between CAC score and exposure group in the model, and comparisons were calculated with the comparison group and a CAC score of ≤100 as reference. The first adjusted analysis was adjusted for age at CCT, sex, and calendar period, and a sensitivity analysis was performed further adjusting for smoking, BMI, diabetes mellitus, hypertension, and dyslipidemia. We performed an additional sensitivity analysis utilizing a Cox proportional hazards regression restricted to cardiovascular mortality. We defined P<0.05 as statistically significant. All statistical analyses were performed with STATA version 14 (STATA Corp, College Station, TX).
RESULTS
We identified 58 799 individuals from the WDHR during the study period January 1, 2008 to December 31, 2016. A total of 10 042 people were excluded, including 9290 (missing CAC score), 3 (died before study entry), 5 (absence of sex information), and 744 (age at CCT below 30 years). Therefore, the final number of individuals included in the current study was 48 757. Among those, a total of 564 patients (1.2%) had previously received a psychiatric diagnosis defined as SMI registered in the Danish National Patient Registry; (schizophrenia [n=236] and bipolar disorder [n=328]).
The sex distribution was similar in both populations, yielding 47.0% in patients with SMI and 48.2% males in the comparison group, P=0.563. The average age at CCT was 53.9±10.4 years in patients diagnosed with SMI and 58.5±11.0 years in the comparison group, respectively (P<0.001). Patients with SMI showed significantly higher rates of smoking (47.9% versus 20.0%), increased mean BMI (27.6 (4.6) versus 26.7 (4.4)), and higher prevalence of diabetes mellitus (11.5% versus 6.1%), all P<0.001. The prevalence of hypertension was significantly higher in the comparison group (37.3% versus 29.6%), P<0.001. We found a similar distribution of family history of coronary artery disease, as well as dyslipidemia between both exposure groups, P>0.05, Table 1 . Table 2 provides a linear regression model utilizing variables predicting CAC score as stratified by SMI status. In the comparison group, the regression model showed that age, male, smoking, diabetes mellitus, hypertension, and dyslipidemia were associated with CAC, whereas patients with SMI showed that age, smoking, BMI, and hypertension were significantly associated with CAC, Table 2 . Table 3 provides a summary of the distribution of CAC scores among the patients with SMI and the comparison group, divided into age categories (≤60 and >60 years). When comparing CAC distribution in patients below the age of 60 years, the frequency of patients with CAC ≤100 and CAC >100 was similar for the 2 groups. The same pattern was observed in the age group above 60 years, Table 3 .
Variables Predicting CAC Score
Severity of CAC
Mortality
The total number of deaths during the study period was 21 (3.7%) in patients with SMI and 1009 (2.1%) in the comparison group, with a mean age at death of 58.7±1.8 years in SMI patients and 70.2±0.4 years in the comparison group, P<0.001. Causes of death showed that the majority of deaths were related to noncardiovascular causes (71.4% in the SMI population and 66% in the comparison group), whereas cardiovascular causes of death accounted for remaining deaths, with no significant differences between groups. The unadjusted Cox proportional hazards regression analy- sis showed that higher CAC score was associated with increased mortality, although mortality rates were significantly higher overall for patients with SMI, P<0.001. When adjusting the primary analysis for age, sex, and calendar period, the comparison group with CAC >100 had an HR of 1.54; 95% CI, 1.38-1.80, SMI patients with CAC ≤100 had an HR of 3.95; 95% CI, 2.36-6.62, and SMI patients with CAC >100 had an HR of 3.16; 95% CI, 1.41-7.06, using the comparison group with CAC ≤100 as reference, Table 4 . Sensitivity analysis adjusting further for cardiovascular risk factors showed similar findings as the main results, Table 4 . The sensitivity analysis of cardiovascular mortality showed nearly similar findings as the primary analysis, but in the fully adjusted model, SMI patients had no increased mortality as compared to the comparison group, Table 5 . Kaplan-Meier curves are reported in Figure and show survival probabilities of patients with SMI and the comparison group stratified by categories of CAC. Overall, increased CAC was associated with increased mortality, P<0.001, log-rank test. Patients with SMI had significantly increased mortality, P<0.01, log-rank test, independent of CAC severity. For the comparison group, patients with CAC>100 had an increased mortality rate as compared to patients with CAC≤100 (P<0.001, log-rank test). For patients with SMI differentiating on CAC >100 or CAC ≤100 did not result in differences in mortality rates between the groups (P=0.22, log-rank test). When comparing CAC scores of ≤100 between patients with SMI and the comparison group, patients with SMI showed an increased mortality rate, P<0.001, log-rank test. The Kaplan-Meier survival probability estimates at 5 years were 0.95 (95% CI, 0.91-0.97) for CAC ≤100, 0.91 (95% CI, 0.79-0.96) for CAC>100 in patients with SMI, 0.98 (95% CI, 0.98-0.98) for CAC≤100, and 0.93 (95% CI, 0.92-0.94) for CAC>100 in the comparison group.
DISCUSSION
In this study of 48 757 individuals who had undergone a CCT resulting in a CAC score during the study period, including 564 (1.2%) patients with previously diagnosed SMI, we showed that there were no differences in CAC scores between patients with SMI and the comparison group. Important variables predicting CAC score in patients with SMI were age, smoking, BMI, and hypertension. When investigating the effect of CAC on mortality rates, we showed that patients with SMI had increased mortality rates independent of CAC severity, CAC ≤100 (HR, 3.86; 95% CI, 2.31-6.46) as well as CAC >100 (HR, 3.07; 95% CI, 1.37-6.87), compared with people with a CAC ≤100 in the comparison group, when adjusting for age, sex, and calendar period. When comparing survival probabilities in patients with SMI and the comparison group divided by CAC severity, we showed that the high CAC score group was associated with increased mortality in the comparison group, whereas there was no effect of CAC score grouping in patients with SMI.
Studies have shown that patients with SMI have increased cardiovascular mortality. 3, 17 Despite relative low numbers of death in patients with SMI, we investigated the association of CAC severity to mortality and showed an increased mortality rate independent of CAC severity in patients with SMI, which might indicate that other contributing factors are involved in the increased mortality, especially when considering the high level of noncardiovascular causes of death. A study by McEvoy et al 18 showed that active smokers had increased mortality (HR, 3.62; 95% CI, 2.28-5.75) compared with nonsmokers in a sample of patients with CAC levels of zero. In our sample, we observed a high prevalence of active smokers in patients with SMI (48% in patients with SMI versus 20% in the compari- son group), but even after adjusting for smoking, the mortality rates remained higher in SMI population. An important risk factor for the progression of CAC is diabetes mellitus. 19 A study by Valenti et al 20 showed that a low CAC score in patients with diabetes mellitus had a favorable short term prognosis, but long-term mortality increased, even in the absence of CAC. Thus, the results of increased levels of cardiovascular risk factors in patients with SMI could indicate that the progression rate of CAC might differ in patients with SMI as compared to the general population or that CAC is of minor importance in cardiovascular mortality in patients with SMI. Given the relatively short follow-up period (≈3 years) and relative young age group (≈56 years) in this study, development of significant coronary artery disease is less likely. No other studies have investigated the progression of CAC in a long-term follow-up study in patients with SMI. However, one ongoing prospective clinical trial might elucidate answers in this topic. 21 Several studies have suggested that patients with higher CAC levels are confounded by an increased likelihood to be intensively treated with statin therapy, 22 as well as an increasing effort to improve medication adherence after CCT, 23 which could influence mortality rates. The results from the present study demonstrate that patients with SMI who have a low CAC score show increased mortality rates as compared to people in the comparison group with low CAC scores. One explanation could be that patients with low CAC score are less likely to initiate prophylactic medical treatment as well as not attending regular follow-ups. Health professionals might be more likely to encourage patients to make lifestyle modifications, which has been proven to be challenging in patients with SMI. 24 Earlier studies have also reported lower rates of revascularization procedures and prophylactic treatment offered to patients with SMI compared with people in the general population. 6, [25] [26] [27] Together, this could be indicative of patients with SMI, who display low or zero CAC score, despite an increased cardiovascular risk profile, are considered low-risk patients and for that reason are not offered sufficient treatment to reduce the overall risk for mortality. The findings from the present study challenge the concept of using CAC as a predictor for mortality in patients with SMI, but given the relatively few events and diminished effect of cardiovascular cause of death in patients with SMI in the current study, no firm conclusions can be drawn, and further studies are needed to address this topic. 
Strengths and Limitations
As a multicenter observational study, generalizability increases into clinical practice easily. Nevertheless, data are not resistant to the limitations of any observational registry, including referral and selection bias. Patients who are referred to a CCT do not necessarily have any cardiovascular disease but are being investigated because of symptoms presented. In the present study, information on cardiovascular risk factors were available if these were reported to the WDHR by the patients, but recall bias could have resulted in misclassification of patient's medication. We solely included patients who had a CCT performed and at the same time had a recorded CAC score. Those patients who were excluded because of missing CAC score did not differ from the current sample in terms of clinical characteristics, which increases the generalizability of the current findings. It is possible that many patients with SMI, who had been referred to CCT, did not turn up to the planned examination or were unable to participate in the examination resulting in no CAC score being reported. The Danish tax-financed healthcare system allows all citizens to be treated equally at any public hospital in Denmark. This minimizes the risk of including a selected group of individuals; However, our findings can be difficult to generalize to findings from countries with a different health care system (eg, social health insurance). Despite the large sample size in the current study, we were unable to include follow-up information on medication use as well as revascularization procedures, which could have had an effect on the mortality rates observed in the present study.
Conclusions
Despite a worse cardiovascular risk profile in patients with SMI, these patients showed a similar CAC score compared with others referred for CCT. The current data show that patients with SMI had increased mortality rates independent of CAC severity, suggesting that CAC in patients with SMI is a poor prognostic tool, although findings may be driven by the low overall number of deaths in the sample.
